≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Polyhydramnios

DOID EFO Endpoint Browser PheWeb

O15_POLYHYDR

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — O40
  • Hospital discharge: ICD-9 — 657
  • Hospital discharge: ICD-8 — 6344
  • Cause of death: ICD-10 — O40
  • Cause of death: ICD-9 — 657
  • Cause of death: ICD-8 — 6344

2 out of 7 registries used, show all original rules.

1908

4. Check minimum number of events

None

1908

5. Include endpoints

None

1908

6. Filter based on genotype QC (FinnGen only)

1908

Control definitions (FinnGen only)

Control exclude
O15_MATERN_CARE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
O30-O48
Name in latin
Hydramnion

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 12633 12633 -
Only index persons 12478 12478 -
Unadjusted period prevalence (%)
Whole population 0.36 0.36 -
Only index persons 0.46 0.46 -
Median age at first event (years)
Whole population - 31.06 -
Only index persons - 31.05 -

-FinnGen-

Key figures

All Female Male
Number of individuals 1908 1908 -
Unadjusted period prevalence (%) 0.65 0.65 -
Median age at first event (years) 31.28 31.28 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1656
Matched controls
16561
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
+∞
323.0
387
*
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
1322.6
323.0
474
5
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
16.1
323.0
637
617
O40
ICD-10 Finland
Polyhydramnios
+∞
323.0
1413
*
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
17.6
275.5
456
349
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
9.5
224.6
516
754
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
15.1
219.1
384
324
O82.0
ICD-10 Finland
Delivery by elective caesarean section
29.3
212.5
292
120
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
7.8
211.7
561
1019
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
5.7
200.2
744
2087
O32.1
ICD-10 Finland
Maternal care for breech presentation
314.3
194.6
194
7
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
7.6
187.4
499
891
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
4.0
153.2
953
4164
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
1541.5
146.1
140
*
MAA00
NOMESCO Finland
Amniocentesis
29.6
145.8
199
76
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
+∞
140.7
133
*
6570A
ICD-9 Finland
Polyhydramnios[POLYHYDRAMNION, RASKAUDEN AIKANA]
+∞
135.3
128
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
4.1
135.1
705
2550
Z39.2
ICD-10 Finland
Routine postpartum follow-up
4.3
132.3
623
2041
SPAT1379
SPAT
Health check-up of pregnant person
4.5
127.0
544
1615
SPAT1197
SPAT
Extensive health check-up of expecting family
4.1
123.9
608
2045
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
184.6
116.0
120
7
SPAT1380
SPAT
Postpartum check-up
4.5
112.4
466
1315
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
18.8
112.0
176
104
O48
ICD-10 Finland
Prolonged pregnancy
1050.8
102.3
99
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
3.6
101.3
596
2257
SPAT1196
SPAT
Monitoring of normal pregnancy
4.8
96.2
365
924
W84
ICPC
Pregnancy high risk
8.3
96.1
226
309
W78
ICPC
Pregnancy
3.4
96.1
624
2531
ZXD05
NOMESCO Finland
Urgent procedure
3.1
92.1
699
3149
63440
ICD-8 Finland
Other complications of pregnancy, Premature rupture of membrane without delivery
+∞
90.4
86
*
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
+∞
84.1
80
*
XMA22
NOMESCO Finland
General examination of pregnant woman
5.0
82.2
290
670
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
+∞
82.0
78
*
O80.8
ICD-10 Finland
Other single spontaneous delivery
6.9
79.7
213
349
Z32.1
ICD-10 Finland
Pregnancy confirmed
3.5
76.1
428
1509
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6.0
75.8
224
418
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
+∞
75.6
72
*
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
3.3
74.0
459
1736
O99.80
ICD-10 Finland
The fear of childbirth
5.2
72.9
244
528
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
+∞
70.3
67
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.3
69.1
282
748
MAC96
NOMESCO Finland
Other induction or advancement of labour
8.0
66.4
157
213
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
4.9
66.0
237
551
O60
ICD-10 Finland
Preterm labour and delivery
12.0
64.9
122
109
O42.0
ICD-10 Finland
Premature rupture of membranes, onset of labour within 24 hours
+∞
61.9
59
*
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
609.5
60.1
59
*
O30.0
ICD-10 Finland
Twin pregnancy
+∞
59.7
57
*
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
3.0
58.7
418
1699
O32.2
ICD-10 Finland
Maternal care for transverse and oblique lie
307.8
58.7
59
*
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
10.9
57.6
113
110
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
3.0
52.7
351
1355
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
5.9
51.9
152
277
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.0
51.3
177
390
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
9.3
51.1
109
124
MAB10
NOMESCO Finland
External version
111.6
50.1
54
5
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
7.7
49.7
120
167
O61.0
ICD-10 Finland
Failed medical induction of labour
19.4
49.6
76
41
SPAT1357
SPAT
Monitoring of problem during pregnancy
5.6
47.9
148
287
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
7.7
47.8
115
159
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
3.4
47.2
255
843
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
4.1
46.7
196
524
SPAT1262
SPAT
Handing over of treatment supplies
3.2
45.1
260
899
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.7
44.7
162
375
SPAT1189
SPAT
Other ultrasound examination during pregnancy
5.0
44.2
151
328
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
3.9
44.0
197
557
WX320
NOMESCO Finland
Spinalanesthesy
2.8
44.0
334
1387
W85
ICPC
Gestational diabetes
4.2
43.5
179
469
O80.0
ICD-10 Finland
Spontaneous vertex delivery
2.0
41.7
845
5603
6570B
ICD-9 Finland
Polyhydramnios[POLYHYDRAMNION, SYNNYTYKSEN AIKANA]
+∞
40.8
39
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
5.3
40.6
129
258
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
40.4
262
977
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
6.9
39.6
102
156
O47.9
ICD-10 Finland
False labour, unspecified
14.5
39.4
67
48
WX307
NOMESCO Finland
Obstetric epidural analgesia
2.6
37.5
303
1294
O20.0
ICD-10 Finland
Threatened abortion
5.8
37.2
109
198
O63.0
ICD-10 Finland
Prolonged first stage (of labour)
7.3
37.1
91
130
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.8
36.5
127
281
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
7.6
36.3
87
120
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
7.3
36.1
89
128
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
5.1
35.9
117
241
O41.0
ICD-10 Finland
Oligohydramnios
+∞
35.5
34
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.9
35.4
120
258
A10AE04
ATC
insulin glargine; parenteral
3.8
35.0
160
458
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
34.4
717
4684
SPAT1263
SPAT
Sampling
1.9
33.8
736
4875
W92
ICPC
Compl labour/ delivery livebirth
7.1
33.8
85
126
WX234
NOMESCO Finland
Paracervical blockade
4.1
33.5
138
360
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
6.2
32.8
91
154
A10AA01
ATC
NA
5.1
32.8
108
225
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
2.1
32.8
430
2323
O02.1
ICD-10 Finland
Missed abortion
3.1
32.6
199
709
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
3.4
32.3
171
550
A10AA02
ATC
NA
5.0
32.3
108
229
O32.0
ICD-10 Finland
Maternal care for unstable lie
323.0
32.0
32
*
O44.0
ICD-10 Finland
Placenta praevia specified as without haemorrhage
323.0
32.0
32
*
A10AE05
ATC
insulin detemir; parenteral
4.2
31.6
125
314
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
+∞
30.3
29
*
O42.1
ICD-10 Finland
Premature rupture of membranes, onset of labour after 24 hours
+∞
30.3
29
*
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
+∞
30.3
29
*
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.7
29.6
87
159
O41.1
ICD-10 Finland
Infection of amniotic sac and membranes
+∞
29.2
28
*
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
5.1
28.9
94
193
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
13.5
28.8
50
38
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
7.8
28.7
67
89
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
17.1
28.5
45
27
O81.4
ICD-10 Finland
Vacuum extractor delivery
2.7
28.3
216
881
O36.4
ICD-10 Finland
Maternal care for intrauterine death
+∞
28.2
27
*
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
5.7
28.0
82
149
H04AA01
ATC
glucagon; nasal, parenteral
4.7
27.2
96
216
8811
FHL
Cesarean section
3.5
26.6
128
382
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
46.5
26.5
32
7
103
Kela drug reimbursment
Diabetes, insulin-treated
2.4
26.5
257
1193
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
26.1
254
1178
O33.5
ICD-10 Finland
Maternal care for disproportion due to unusually large fetus
+∞
26.1
25
*
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
2.2
25.8
289
1437
LGA20
NOMESCO Finland
Sterilisation by constriction of Fallopian tubes
9.6
25.8
53
57
SPAT1301
SPAT
No procedures
1.9
25.7
478
2915
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
13.7
25.5
44
33
W90
ICPC
Uncompl labour/delivery livebirth
2.9
24.8
158
576
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
5.5
24.5
74
140
T89
ICPC
Diabetes insulin dependent
3.8
24.1
107
298
MAE00
NOMESCO Finland
Outlet vacuum delivery
2.6
23.8
183
747
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
8.3
23.7
53
66
Z36.8
ICD-10 Finland
Other antenatal screening
4.3
23.2
88
213
O64.0
ICD-10 Finland
Obstructed labour due to incomplete rotation of fetal head
4.7
23.1
80
177
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
2.8
22.4
150
562
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
12.9
22.2
39
31
O44.1
ICD-10 Finland
Placenta praevia with haemorrhage
+∞
21.9
21
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
21.8
654
4599
Z3232
NOMESCO Finland
Midwife
2.0
21.8
306
1665
SPAT1200
SPAT
Guidance for breast-feeding and breast care
3.7
21.2
95
267
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
9.2
21.1
44
49
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
3.2
21.1
113
366
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
3.0
21.0
130
464
MAA96
NOMESCO Finland
Other intrauterine operation on pregnant uterus or fetus
28.4
21.0
28
10
A10AE06
ATC
insulin degludec; parenteral
4.3
20.9
79
191
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
7.8
20.9
48
63
MAB20
NOMESCO Finland
Failed external version
111.4
20.6
22
*
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
7.8
20.4
47
62
Z39.1
ICD-10 Finland
Care and examination of lactating mother
4.2
20.4
78
191
W29
ICPC
Pregnancy symptom/complaint other
3.6
19.8
92
267
B01AB05
ATC
enoxaparin; parenteral
1.8
19.5
363
2184
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.5
19.4
69
157
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
+∞
18.8
18
*
MAX99
NOMESCO Finland
Assistance to normal delivery
1.9
18.5
300
1715
Z30.2
ICD-10 Finland
Sterilization
2.0
18.3
240
1265
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
3.2
18.1
98
320
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
5.7
17.9
51
91
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
3.1
17.9
103
352
O35.0
ICD-10 Finland
Maternal care for (suspected) central nervous system malformation in fetus
+∞
17.7
17
*
J01DB01
ATC
cefalexin; oral
1.7
17.7
1340
11774
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
7.6
17.7
41
55
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
17.3
1238
10657
E66.01
ICD-10 Finland
Obesity due to excess calories
2.2
17.3
190
927
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
3.3
17.2
90
287
SPAT1312
SPAT
General health counselling
1.6
17.1
523
3632
SPAT1307
SPAT
Psychosocial counselling and guidance
2.3
17.1
169
786
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
50.5
17.0
20
*
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
+∞
16.7
16
*
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
6.3
16.3
43
70
H3600, E103
ICD-10 Finland
NA
5.6
16.2
47
86
WX290
NOMESCO Finland
Other blockade of nerve
1.5
16.2
867
6892
SPAT1324
SPAT
Screening procedure
1.6
16.1
535
3789
O65.4
ICD-10 Finland
Obstructed labour due to fetopelvic disproportion, unspecified
11.8
16.1
29
25
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
3.7
16.1
71
199
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
9.1
15.9
33
37
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
9.6
15.9
32
34
G02CB01
ATC
bromocriptine; systemic
3.9
15.8
65
171
O23.5
ICD-10 Finland
Infections of the genital tract in pregnancy
6.3
15.7
41
66
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
15.3
229
1265
A10BA02
ATC
metformin; oral
1.9
15.2
232
1292
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
2.4
15.2
134
589
SPAT1315
SPAT
Periodic health check-up of children and adolescents
2.7
15.0
108
424
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
15.0
701
5366
O80.9
ICD-10 Finland
Single spontaneous delivery, unspecified
5.5
15.0
44
82
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
14.9
998
8273
SGA01
NOMESCO Finland
Tooth opening as first aid
1.8
14.8
312
1934
K02.1
ICD-10 Finland
Caries of dentine
1.5
14.7
1005
8362
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
14.6
484
3404
O45.9
ICD-10 Finland
Premature separation of placenta, unspecified
+∞
14.6
14
*
O36.0
ICD-10 Finland
Maternal care for rhesus isoimmunization
+∞
14.6
14
*
O34.0
ICD-10 Finland
Maternal care for congenital malformation of uterus
+∞
14.6
14
*
6441A
ICD-9 Finland
Early or threatened labour, Other threatened labour
+∞
14.6
14
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
4.8
14.6
48
102
J01DA01
ATC
[U] cefalexin; systemic
1.5
14.5
1001
8333
O84.0
ICD-10 Finland
Multiple delivery, all spontaneous
151.3
14.5
15
*
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.8
14.4
288
1759
SPAT1192
SPAT
Gynaecological examination
1.7
14.3
325
2059
SPAT1310
SPAT
Counselling related to known health issue
1.6
14.1
459
3210
SPAT1240
SPAT
Therapeutic discussion
1.8
14.1
251
1471
O64.1
ICD-10 Finland
Obstructed labour due to breech presentation
8.2
13.8
30
37
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
4.8
13.7
45
96
O68.3
ICD-10 Finland
Labour and delivery complicated by biochemical evidence of fetal stress
8.0
13.6
30
38
MAA06
NOMESCO Finland
Amnioreduction
+∞
13.6
13
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
13.4
278
1714
R51.80
ICD-10 Finland
Headache
1.7
13.3
286
1782
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
13.3
189
1024
SPAT1303
SPAT
Counselling and guidance related to growth and development
6.5
12.9
33
52
SPAT1373
SPAT
Combined screening in early pregnancy
4.0
12.9
51
131
ZXE00
NOMESCO Finland
One hour or less
1.5
12.9
595
4499
N02BE01
ATC
paracetamol; systemic, rectal
1.6
12.8
1318
11804
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
12.6
434
3065
WX230
NOMESCO Finland
Plexus blockade of nervus pudendus
4.3
12.6
46
110
6581A
ICD-9 Finland
Other problems associated with amniotic cavity and membranes, Premature rupture of membranes
+∞
12.5
12
*
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
+∞
12.5
12
*
O61.1
ICD-10 Finland
Failed instrumental induction of labour
20.2
12.5
18
9
NE1AG
NOMESCO Finland
MRI pelvimetry with high intensity magnet
131.0
12.4
13
*
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
2.7
12.4
85
325
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
3.8
12.4
52
141
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
3.5
12.3
57
168
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
12.3
210
1214
SPAT1153
SPAT
Removal of sutures
1.6
12.2
347
2330
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.8
12.2
206
1183
SPAT1283
SPAT
Restricted health certificate
1.5
12.0
465
3367
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
4.9
11.9
38
79
SPAT1391
SPAT
Counselling and guidance related to family situation
4.4
11.9
42
97
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
11.8
886
7349
W30
ICPC
Pregnancy, Medical examin/health eval complete
6.2
11.8
31
51
O75.0
ICD-10 Finland
Maternal distress during labour and delivery
4.1
11.8
45
112
177
Kela drug reimbursment
Insulin glargine 300 U / ml
4.2
11.6
43
104
E66.9
ICD-10 Finland
Obesity, unspecified
2.8
11.6
76
282
O64.8
ICD-10 Finland
Obstructed labour due to other malposition and malpresentation
8.2
11.6
25
31
MBC10
NOMESCO Finland
Repair of obstetric laceration of vagina
3.2
11.5
60
193
MA2BG
NOMESCO Finland
Fetal examination with high intensity magnet
+∞
11.5
11
*
6510B
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, SYNNYTYKSEN AIKANA]
+∞
11.5
11
*
6510A
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]
+∞
11.5
11
*
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
3.4
11.4
55
167
O33.9
ICD-10 Finland
Maternal care for disproportion, unspecified
120.8
11.4
12
*
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
3.5
11.3
51
147
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.6
11.3
388
2728
O28.1
ICD-10 Finland
Abnormal biochemical finding on antenatal screening of mother
7.1
11.0
26
37
TMW99
NOMESCO Finland
Other minor surgical procedure in obstetrics
5.6
11.0
31
56
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.2
10.9
115
549
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.8
10.8
193
1131
SPAT1383
SPAT
Extensive health check-up at 4 years of age
4.9
10.7
34
71
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.6
659
5231
XMA20
NOMESCO Finland
Early examination of pregnancy
3.6
10.6
46
129
O14.1
ICD-10 Finland
Severe pre-eclampsia
5.3
10.6
31
59
A02BC01
ATC
omeprazole; systemic
1.6
10.5
323
2206
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
5.7
10.4
29
52
6440B
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]
4.9
10.2
32
66
Z34
ICD-10 Finland
Supervision of normal pregnancy
2.0
10.2
130
675
Z36.2
ICD-10 Finland
Other antenatal screening based on amniocentesis
13.2
10.2
17
13
SPAT1393
SPAT
Guidance to support interaction between parent and child
7.7
9.9
22
29
ZXD00
NOMESCO Finland
Emergency procedure
3.0
9.9
57
197
W18
ICPC
Post-partum symptom/complaint other
6.3
9.9
25
40
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.5
9.8
28
52
O23.1
ICD-10 Finland
Infections of bladder in pregnancy
9.6
9.8
19
20
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
3.6
9.8
43
123
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.7
497
3788
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.5
9.6
33
75
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
9.5
101
485
O12.1
ICD-10 Finland
Gestational proteinuria
5.5
9.5
27
50
MA3AE
NOMESCO Finland
Combined first trimester screening
2.1
9.5
114
576
O46.8
ICD-10 Finland
Other antepartum haemorrhage
+∞
9.4
9
*
O68.8
ICD-10 Finland
Labour and delivery complicated by other evidence of fetal stress
4.1
9.4
35
87
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
9.2
877
7454
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.6
9.1
39
109
W31
ICPC
Pregnancy, Medical examin/health eval partial
3.1
9.1
48
158
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
36.9
9.0
11
*
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
2.6
9.0
62
241
W27
ICPC
Fear of complications of pregnancy
4.1
9.0
33
81
O26.9
ICD-10 Finland
Pregnancy-related condition, unspecified
6.5
9.0
22
34
MBA20
NOMESCO Finland
Expression of placenta
5.8
8.9
24
42
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
5.0
8.8
27
55
Z31.5
ICD-10 Finland
Genetic counselling
2.0
8.8
105
533
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
5.1
8.6
26
52
H36.00
ICD-10 Finland
Diabetic background retinopathy
4.3
8.6
30
70
A10BK01
ATC
dapagliflozin; oral
3.2
8.6
44
142
G03GA01
ATC
chorionic gonadotrophin; parenteral
1.9
8.6
116
617
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
2.6
8.6
59
230
MAG00
NOMESCO Finland
Assisted breech delivery
16.4
8.6
13
8
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
2.2
8.5
82
378
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
8.5
315
2235
SPAT1260
SPAT
Consultation of another employee
1.6
8.5
225
1475
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
8.5
786
6612
H01
ICPC
Ear pain/earache
1.7
8.5
188
1175
SPAT1316
SPAT
Extensive health check-up of children and adolescents
2.3
8.4
73
321
O42.2
ICD-10 Finland
Premature rupture of membranes, labour delayed by therapy
+∞
8.3
8
*
O41.9
ICD-10 Finland
Disorder of amniotic fluid and membranes, unspecified
+∞
8.3
8
*
O33.2
ICD-10 Finland
Maternal care for disproportion due to inlet contraction of pelvis
+∞
8.3
8
*
6450B
ICD-9 Finland
Prolonged pregnancy[GRAVIDITAS PROLANGATA CUM PARTU]
+∞
8.3
8
*
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.2
8.3
79
364
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
4.6
8.3
27
59
B02AA02
ATC
tranexamic acid; systemic
1.5
8.3
291
2040
MAA10
NOMESCO Finland
Biopsy of chorionic villus
10.8
8.3
15
14
Z29
ICPC
Social problem NOS
3.7
8.2
34
93
C08CA05
ATC
nifedipine; systemic
2.5
8.2
61
248
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
8.2
96
481
WX110
NOMESCO Finland
Local anesthesy
1.4
8.2
1121
10013
SPAT1370
SPAT
Other health check-up
2.6
8.1
59
236
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.1
8.1
30
75
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
8.0
136
785
G03GB02
ATC
clomifene; oral
2.7
8.0
53
203
SPAT1375
SPAT
Structural ultrasound screening, weeks 18+0-21+6
4.1
8.0
29
71
OAA12
SPAT
NA
2.8
7.9
47
168
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
0.5
7.9
52
1061
H3603, E103
ICD-10 Finland
NA
3.6
7.9
34
97
O72.0
ICD-10 Finland
Third-stage haemorrhage
2.5
7.9
58
235
EBA00
NOMESCO Finland
Extraction of tooth
1.4
7.9
463
3596
SPAT1187
SPAT
General ultrasound examination in early pregnancy
3.9
7.9
30
77
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.7
1120
10039
K04.0
ICD-10 Finland
Pulpitis
1.6
7.6
187
1201
O64.4
ICD-10 Finland
Obstructed labour due to shoulder presentation
25.1
7.6
10
*
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
8.9
7.5
15
17
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
7.5
155
950
SPAT1193
SPAT
Pap smear
1.5
7.5
279
1981
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
1.6
7.4
173
1098
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.5
7.4
32
92
O72.1
ICD-10 Finland
Other immediate postpartum haemorrhage
2.3
7.3
63
276
O32.8
ICD-10 Finland
Maternal care for other malpresentation of fetus
+∞
7.3
7
*
O34.3
ICD-10 Finland
Maternal care for cervical incompetence
+∞
7.3
7
*
6584B
ICD-9 Finland
Other problems associated with amniotic cavity and membranes, Infection of amniotic cavity[AMNIONITIS, SYNNYTYKSEN AIKANA]
+∞
7.3
7
*
O36.2
ICD-10 Finland
Maternal care for hydrops fetalis
+∞
7.3
7
*
O33.3
ICD-10 Finland
Maternal care for disproportion due to outlet contraction of pelvis
+∞
7.3
7
*
Z37.0
ICD-10 Finland
Single live birth
1.5
7.2
257
1804
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
6.3
7.2
18
29
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
7.2
173
1105
H3601, E103
ICD-10 Finland
NA
4.3
7.2
25
59
O47
ICD-10 Finland
False labour
4.6
7.2
23
50
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
3.8
7.2
28
74
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.5
7.1
236
1631
C07AG01
ATC
labetalol; systemic
3.3
7.1
34
106
O91.2
ICD-10 Finland
Nonpurulent mastitis associated with childbirth
3.3
7.1
34
106
SPAT1195
SPAT
Antenatal classes
2.1
7.1
79
390
M54.5
ICD-10 Finland
Low back pain
1.4
7.1
502
4012
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.9
7.0
103
565
HMAK
NOMESCO Finland
NA
1.5
7.0
215
1462
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.8
7.0
42
153
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
6.3
6.9
17
27
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.3
6.9
32
98
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
6.8
539
4378
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.6
6.8
185
1223
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
6.1
6.8
17
28
O20.8
ICD-10 Finland
Other haemorrhage in early pregnancy
5.7
6.8
18
32
SPAT1389
SPAT
Visit based on need for special support
2.4
6.7
55
238
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.7
620
5151
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
6.7
110
627
6440A
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]
2.9
6.7
37
128
WX600
NOMESCO Finland
Single shot through catheter
2.8
6.6
40
146
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
6.6
104
586
O62.0
ICD-10 Finland
Primary inadequate contractions
6.5
6.6
16
25
N05AH02
ATC
clozapine; systemic
0.1
6.6
*
222
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.6
6.6
46
181
SPAT1382
SPAT
Extensive health check-up at 18 months of age
4.4
6.5
22
51
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.5
129
781
SPAT1097
SPAT
Recording of ECG
1.7
6.5
117
691
CKC15
NOMESCO Finland
Panretinal photocoagulation
5.3
6.5
18
34
Z37.1
ICD-10 Finland
Single stillbirth
70.1
6.4
7
*
CKC12
NOMESCO Finland
Photocoagulation of retina
2.4
6.4
49
204
Z22
ICPC
Illness problem parent/family memb
6.6
6.3
15
23
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
6.6
6.3
15
23
W05
ICPC
Pregnancy vomiting/nausea
3.5
6.3
27
78
MBA30
NOMESCO Finland
Manual removal of placenta from delivered uterus
2.6
6.3
43
170
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
11.1
6.3
11
10
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.6
6.3
20
44
O43.0
ICD-10 Finland
Placental transfusion syndromes
+∞
6.3
6
*
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
+∞
6.3
6
*
6412B
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Premature separation of placenta[ABLATIO PLACENTAE ANTETEMPUS,SYNN PÄÄTT HOITOJAKSO]
+∞
6.3
6
*
N61
ICD-10 Finland
Inflammatory disorders of breast
2.1
6.2
66
320
MAC98
NOMESCO Finland
Other induction of labor
26.8
6.2
8
*
O69.1
ICD-10 Finland
Labour and delivery complicated by cord around neck, with compression
4.8
6.2
19
40
SFA00
NOMESCO Finland
Small filling
1.5
6.2
182
1223
WX720
NOMESCO Finland
Own respiration
2.5
6.2
45
183
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.2
431
3421
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
7.0
6.2
14
20
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
1.4
6.2
337
2567
A05AA02
ATC
ursodeoxycholic acid; oral
3.0
6.2
32
107
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.5
6.2
214
1497
G03DB01
ATC
dydrogesterone; oral
1.4
6.1
291
2162
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.5
6.1
179
1201
O66.2
ICD-10 Finland
Obstructed labour due to unusually large fetus
8.6
6.1
12
14
O68.1
ICD-10 Finland
Labour and delivery complicated by meconium in amniotic fluid
4.4
6.0
20
46
O21
ICD-10 Finland
Excessive vomiting in pregnancy
4.2
6.0
21
51
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
4.2
6.0
21
51

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
378
788
5.74
177.43
1.7
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
338
737
5.36
149.62
2.0
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
277
624
5.02
116.84
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
504
2009
3.05
91.26
1.6
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
365
1351
3.10
73.85
1.6
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
133
257
5.49
65.99
1.8
1.5
mmol/l
7.8
7.7
0.26
70
147
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
471
2125
2.62
64.85
2.1
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
771
4423
2.25
61.14
1.9
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
667
3645
2.28
59.10
1.7
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
145
376
4.09
50.07
2.3
2.1
umol/l
4.1
5.8
0.94
112
293
(3013826) Glucose [Moles/volume] in Serum or Plasma
1038
7184
1.98
45.45
4.6
3.7
mmol/l
6.6
6.2
4.98
881
6559
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
992
7151
1.81
34.47
4.4
3.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
861
5982
1.80
33.57
4.0
3.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
363
1908
2.11
32.77
2.6
2.1
u/l
9374.6
5366.3
1.37
170
704
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
98
284
3.58
28.76
1.8
1.4
mmol/l
6.6
7.1
0.88
66
205
(3029937) Albumin [Presence] in Urine by Test strip
600
3891
1.79
28.37
4.1
3.2
estimate
0.0
0.0
1.08
212
1455
(3031040) Bacteria [#/volume] in Urine by Automated count
1259
10053
1.74
27.83
4.7
3.5
e6/l
86.8
1512.4
2.93
12
107
(3019150) Specific gravity of Urine by Refractometry
500
3128
1.81
26.34
4.1
3.1
kg/l
1.0
1.0
0.79
102
429
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
63
142
4.55
26.03
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1298
10557
1.72
25.73
4.7
3.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
587
3910
1.72
24.60
2.6
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1005
7713
1.64
24.28
4.1
3.0
estimate
0.0
0.0
1.79
215
1446
(3021601) Nitrite [Presence] in Urine by Test strip
997
7647
1.64
24.05
5.4
4.3
estimate
0.0
0.0
0.80
219
1478
(3035350) Ketones [Presence] in Urine by Test strip
992
7625
1.63
23.52
4.0
3.0
estimate
0.0
0.0
0.50
214
1420
(46235355) HIV 1 and 2 tests - Meaningful Use set
790
5767
1.63
22.90
2.0
2.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
407
2500
1.80
22.32
4.8
4.1
mg/mmol
8.5
12.2
1.02
306
1588
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
84
270
3.21
20.97
1.6
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
387
2419
1.75
19.74
3.8
3.4
mg/l
205.8
398.3
0.52
276
1484
(3041096) Erythrocytes [Presence] in Urine by Automated
624
4548
1.55
16.88
3.5
2.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
36
75
4.87
16.39
3.6
2.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
59
180
3.35
16.06
2.9
2.6
ug/min
53.6
117.6
0.86
45
124
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
47
123
3.89
16.04
2.3
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1134
9437
1.50
15.92
3.4
3.0
ug/l
59.1
61.1
0.30
1089
9038
(3019550) Sodium [Moles/volume] in Serum or Plasma
1652
15030
1.74
14.99
9.9
8.9
mmol/l
139.5
139.5
0.05
1619
14578
(3023103) Potassium [Moles/volume] in Serum or Plasma
1655
15074
1.74
14.84
10.0
8.9
mmol/l
3.9
3.9
0.04
1620
14591
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
550
3995
1.53
14.72
2.9
2.5
u/l
55.1
54.3
0.07
531
3715
(1761482) Bacteria [#/volume] in Urine by Culture
66
231
2.92
14.30
4.0
3.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
43
115
3.80
14.26
1.4
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1538
13801
1.59
14.02
5.0
4.3
pmol/l
14.3
14.2
0.51
1465
13047
(3009508) Creatinine [Moles/volume] in Urine
453
3184
1.55
13.97
3.6
3.2
mmol/l
8.1
7.6
1.36
402
2773
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
502
3703
1.48
12.07
2.5
2.4
ng/l
26.8
22.5
0.16
177
1397
(3032080) INR in Blood by Coagulation assay
496
3689
1.47
11.33
4.8
4.9
inr
1.0
1.1
0.43
174
1305
(3003694) ABO and Rh group [Type] in Blood
679
5364
1.41
11.13
2.2
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
118
611
1.99
10.73
1.3
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1666
15473
1.60
10.58
5.8
4.9
mu/l
1.6
1.9
1.72
1598
14804
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
61
241
2.58
10.57
2.5
2.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1809
17192
2.01
10.55
11.4
8.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
572
4419
1.42
10.51
2.1
1.9
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
18
30
6.05
10.39
1.6
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
61
251
2.48
9.74
1.1
1.1
iu/ml
10.5
1293.5
0.55
21
64
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
86
415
2.12
9.48
2.3
2.4
g/l
3.7
3.6
0.57
79
387
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
34
105
3.28
9.18
1.5
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
93
475
2.01
8.83
4.8
6.5
mmol/l
23.7
24.3
0.76
83
440
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
82
401
2.09
8.76
1.9
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
640
5164
1.36
8.72
1.9
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
234
1577
1.55
8.41
1.8
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
175
1102
1.65
8.35
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1412
12865
1.38
8.30
5.8
3.9
mmol/mol
39.9
37.0
17.38
1346
12277
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
584
4674
1.36
8.30
1.4
1.3
u/ml
1.1
1.4
0.74
178
1355
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
157
973
1.67
7.97
2.6
4.0
u/l
221.5
232.5
0.56
145
920
(3000330) Specific gravity of Urine by Test strip
100
543
1.89
7.97
3.9
2.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
70
335
2.13
7.93
1.4
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
460
3567
1.38
7.91
1.8
1.7
mg/l
0.8
0.7
0.64
361
2606
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
53
226
2.38
7.89
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
348
2574
1.43
7.87
1.6
1.5
pmol/l
92026992.4
29011415.0
0.71
301
2275
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
464
3621
1.37
7.64
2.5
2.1
mg/l
2.7
2.7
0.04
410
3122
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
425
3274
1.38
7.57
1.3
1.3
iu/ml
23.6
22.4
0.10
132
1004
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1699
16070
1.52
7.52
11.4
9.5
mg/l
16.7
18.1
1.25
1421
12022
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
66
318
2.11
7.37
1.4
1.4
u/ml
111.7
115.6
0.18
20
62
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
688
5729
1.31
7.24
6.2
5.3
mmol/l
1.2
1.2
0.06
585
4866
(3019060) Gas panel - Arterial blood
88
475
1.89
7.17
3.5
4.6
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
11
16
6.91
7.15
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
178
1171
1.57
7.11
1.5
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
70
351
2.03
7.05
3.5
3.3
g/l
0.2
0.4
1.37
33
141
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
192
1289
1.54
7.01
1.6
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
56
258
2.21
7.01
1.6
1.9
ug/l
1.1
2.6
0.60
47
224
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
177
1170
1.57
6.92
1.5
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
389
3004
1.37
6.75
2.2
2.0
umol/l
283.7
2724.3
5.68
342
2707
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
177
1180
1.55
6.67
1.5
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
177
1181
1.55
6.65
1.6
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
327
2460
1.40
6.64
3.2
3.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1880
18354
2.66
6.62
16.9
14.5
e9/l
267.0
274.1
5.69
1859
17991
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
398
3096
1.36
6.58
1.4
1.3
u/ml
8.0
11.0
0.49
175
1341
(3047181) Lactate [Moles/volume] in Blood
60
294
2.07
6.45
3.4
4.9
mmol/l
1.4
1.2
1.31
51
257
(3035941) MCH [Entitic mass]
1880
18372
2.59
6.27
16.8
14.4
pg
29.8
29.9
3.66
1872
18208
(3026361) Erythrocytes [#/volume] in Blood
1880
18376
2.57
6.19
16.9
14.5
e12/l
4.5
4.5
1.67
1860
18004
(3010813) Leukocytes [#/volume] in Blood
1880
18381
2.55
6.10
16.9
14.5
e9/l
6.9
6.7
3.97
1857
17989
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
23
5.24
6.01
1.0
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1880
18387
2.53
5.98
17.0
14.5
g/l
131.9
133.4
7.22
1871
18219
(3024731) MCV [Entitic volume]
1879
18373
2.49
5.98
16.8
14.4
fl
89.3
90.0
8.64
1872
18211
(40761536) Microorganisms panel - Urine sediment
186
1286
1.49
5.93
3.4
3.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
397
3140
1.33
5.82
1.9
2.0
u/l
114.8
147.5
0.66
386
2989
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1164
10553
1.26
5.70
6.7
6.4
u/l
72.6
70.8
0.98
1098
9995
(3040151) Glucose [Moles/volume] in Capillary blood
28
103
2.74
5.70
3.9
4.7
mmol/l
6.7
7.7
0.29
23
85
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
763
6603
1.26
5.53
4.9
5.0
umol/l
8.9
9.3
0.90
725
6189
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
215
1551
1.44
5.51
1.7
1.8
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
31
126
2.48
5.21
1.1
1.1
ratio
1.1
1.0
—
8
52
(3002385) Erythrocyte distribution width [Ratio]
1522
14325
1.31
5.20
13.0
11.8
%
13.4
13.5
1.94
1496
14064
(3026782) Osmolality of Urine
302
2330
1.35
5.19
3.0
2.4
mosm/kgh2o
540.1
531.1
0.24
263
1985
(3022621) pH of Urine by Test strip
135
898
1.54
5.18
3.4
2.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
236
1751
1.40
5.17
2.2
2.5
ng/l
1016.2
417.5
0.66
197
1397
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
104
653
1.63
5.10
1.5
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
604
5136
1.26
4.97
4.7
4.1
g/l
36.5
37.1
1.90
577
4795
(36660697) Celiac disease serology panel - Serum
216
1596
1.40
4.85
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
132
888
1.52
4.83
3.7
3.0
mmol/l
1.2
1.2
1.83
111
773
(3013512) EKG study
355
2833
1.31
4.82
2.6
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
417
3412
1.28
4.68
4.1
3.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
644
5554
1.24
4.60
1.6
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1740
16774
1.42
4.57
9.0
8.0
u/l
23.7
23.5
0.27
1698
16360
(3044889) 12 lead EKG panel
994
8991
1.22
4.43
2.6
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
316
2512
1.31
4.40
2.8
2.3
e6/l
7.9
9.7
1.06
276
2189
(3002173) Hemoglobin [Mass/volume] in Arterial blood
113
751
1.54
4.39
6.5
7.4
g/l
122.3
122.0
0.07
108
724
(40761535) Cells panel - Urine sediment
129
883
1.49
4.37
4.0
3.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
116
783
1.51
4.21
6.3
7.1
%
96.6
96.3
0.19
110
753
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
62
2.92
4.17
1.2
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
25
103
2.45
4.14
1.2
1.1
—
34.1
—
0
10
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
170
1241
1.41
4.11
1.5
1.5
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
7
7
10.03
4.01
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
254
1984
1.32
4.00
2.7
2.3
umol/l
14.5
14.6
0.06
237
1865
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
75
2.68
3.99
1.6
1.8
u/field
0.7
3.6
—
9
39
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
18
64
2.83
3.96
1.1
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
97
639
1.55
3.95
1.1
1.1
u/ml
1.5
3.8
—
9
129
(3037522) Nuclear Ab [Titer] in Serum
318
2571
1.28
3.88
1.4
1.4
titre
405.8
600.1
1.53
48
526
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
79
505
1.59
3.68
2.1
2.2
iu/l
6.0
3.8
0.71
30
224
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
24
103
2.35
3.67
1.1
1.1
miu/ml
1275.3
1573.5
0.77
24
103
(3021589) Normoblasts [#/volume] in Blood
765
6833
1.20
3.64
8.0
7.7
e9/l
0.0
0.0
0.87
676
5606
(3020891) Body temperature
50
284
1.78
3.62
3.9
4.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1216
11341
1.20
3.53
4.1
3.6
mm/h
9.2
9.2
0.08
1158
10685
(3004789) Transferrin [Mass/volume] in Serum or Plasma
226
1772
1.31
3.48
2.6
2.3
g/l
2.6
2.5
0.88
207
1662
(3002032) Base excess in Venous blood by calculation
111
777
1.46
3.42
3.5
3.7
mmol/l
2.1
1.7
0.78
85
612
(3014576) Chloride [Moles/volume] in Serum or Plasma
144
1059
1.39
3.37
6.7
6.3
mmol/l
104.9
104.9
0.09
139
1042
(1616796) Gas panel - Central venous blood
38
203
1.89
3.35
4.1
2.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
61
375
1.65
3.35
1.3
1.2
u/ml
259.9
273.3
0.17
40
255
(3018677) aPTT in Platelet poor plasma by Coagulation assay
199
1542
1.32
3.34
1.9
2.0
s
28.6
29.2
1.27
192
1483
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
142
2.06
3.27
1.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
129
940
1.40
3.20
6.2
6.5
mmol/l
1.1
0.6
0.80
83
698
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
53
854
0.61
3.20
1.4
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
91
621
1.49
3.20
1.4
1.4
u/l
23.8
21.6
0.23
69
520
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
63
396
1.61
3.19
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
176
2266
0.75
3.18
1.4
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
53
319
1.68
3.17
1.9
2.0
g/l
1.2
1.3
0.34
44
272
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
17
67
2.55
3.13
1.2
1.5
u/field
1.0
2.6
1.29
12
48
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
17
67
2.55
3.13
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
47
275
1.73
3.12
4.3
3.1
mg/l
21.1
20.7
0.03
37
172
(3036481) Cortisol [Moles/volume] in Serum or Plasma
208
1638
1.30
3.11
1.9
2.1
nmol/l
377.4
374.0
0.09
187
1509
(3042936) Bacteria identified in Isolate by Culture
212
1676
1.30
3.09
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
131
966
1.38
3.05
1.5
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
427
3665
1.21
3.02
3.3
2.7
e6/l
19.7
84.0
2.09
334
2715
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
127
935
1.38
2.99
6.3
6.4
kpa
4.8
5.0
3.11
120
893
(3027801) Oxygen [Partial pressure] in Arterial blood
127
935
1.38
2.99
6.3
6.4
kpa
13.1
13.9
0.94
120
892
(3041806) Other cells [#/volume] in Blood by Manual count
5
177
0.28
2.97
1.2
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
133
990
1.37
2.93
1.5
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
510
1.51
2.92
2.1
2.0
ug/l
2.1
5.0
5.41
65
443
(3048929) Epstein Barr virus Ab [Presence] in Serum
105
752
1.42
2.90
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
220
1772
1.27
2.78
1.7
1.6
nmol/l
1226.5
1187.1
0.27
194
1375
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
23
3.93
2.77
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
237
2883
0.80
2.73
1.3
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
91
643
1.44
2.72
1.9
2.5
e9/l
66.9
72.9
0.89
75
456
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
57
365
1.58
2.72
3.3
2.9
%
0.8
0.7
1.01
50
356
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
235
1.72
2.66
1.2
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
588
5250
1.17
2.63
3.1
2.9
u/l
26.0
28.2
1.25
561
5016
(44806118)
25
127
1.98
2.60
1.0
1.4
—
—
—
0
0
(44790047)
25
127
1.98
2.60
1.0
1.4
—
—
—
0
0
(44790048)
25
127
1.98
2.60
1.0
1.4
—
—
—
0
0
(44790049)
25
127
1.98
2.60
1.0
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
106
778
1.38
2.58
1.2
1.3
u/ml
0.6
1.5
—
10
66
(3003458) Phosphate [Moles/volume] in Serum or Plasma
161
1259
1.30
2.57
6.7
5.4
mmol/l
1.0
1.0
0.09
151
1193
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
569
5079
1.17
2.54
5.4
4.6
mmol/l
1.2
1.2
1.65
514
4657
(3033705) Calcium.ionized [Moles/volume] in Venous blood
20
95
2.12
2.49
1.2
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
489
4319
1.18
2.48
2.0
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
307
2605
1.21
2.43
1.5
1.4
nmol/l
19.9
20.8
0.56
277
2353
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
40
242
1.67
2.42
1.2
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
42
258
1.64
2.40
4.1
3.5
nmol/l
0.8
0.9
0.45
32
224
(3013166) Neutrophils/100 leukocytes in Synovial fluid
8
22
3.65
2.36
1.4
1.4
%
22.2
40.3
—
8
17
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
17
4.13
2.36
13.6
4.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
111
1.99
2.36
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
37
221
1.69
2.35
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
117
890
1.34
2.30
2.1
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1535
14813
1.19
2.29
4.0
3.8
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
18
85
2.13
2.29
1.1
1.0
%
102.1
88.8
1.95
13
70
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
605
0.62
2.27
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
161
1284
1.28
2.24
5.3
4.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
63
433
1.47
2.23
1.4
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
220
1821
1.24
2.23
2.3
2.7
ng/l
746.1
327.6
0.29
98
850
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
62
425
1.47
2.22
2.2
1.9
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
20
100
2.01
2.21
1.2
1.8
mmol/l
3.9
3.9
0.00
20
100
(3035285) Chloride [Moles/volume] in Venous blood
20
100
2.01
2.21
1.2
1.8
mmol/l
105.2
105.8
0.21
20
100
(3051101) Glucose [Moles/volume] in Cord blood
6
14
4.30
2.15
6.8
2.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
68
2.22
2.11
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
24
131
1.84
2.08
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
130
1641
0.78
2.07
1.2
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
146
1.79
2.06
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
377
3307
1.17
2.06
2.1
1.8
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
70
500
1.42
2.05
1.9
2.0
%
90.3
96.1
1.22
61
464
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
25
140
1.80
2.01
1.4
2.1
u/ml
5.6
37.2
0.49
20
116
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
67
478
1.42
1.98
2.4
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
193
1599
1.23
1.96
2.7
2.4
%
24.2
24.1
0.03
163
1403
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
54
371
1.47
1.95
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
77
567
1.37
1.91
2.0
2.0
s
20.9
20.6
0.38
54
480
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
92
1.97
1.90
1.3
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
166
1.70
1.88
1.2
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
62
445
1.41
1.80
9.0
8.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
81
609
1.34
1.78
1.5
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
377
3346
1.16
1.78
3.2
2.6
e6/l
0.2
0.3
1.37
302
2420
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
81
1.98
1.74
1.6
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
43
290
1.49
1.73
1.3
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
153
1851
0.81
1.72
1.6
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
177
0.45
1.70
1.3
2.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
133
1079
1.25
1.67
1.6
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
172
1435
1.22
1.66
3.2
3.4
pmol/l
4.5
4.5
0.14
157
1276
(44806071)
7
25
2.81
1.65
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1496
14514
1.14
1.62
3.5
3.3
mmol/l
5.8
5.5
8.71
1416
13754
(3018418) pH of Serum or Plasma
384
3437
1.15
1.61
4.2
3.5
ph
7.4
7.4
0.27
78
637
(3047352) Trisomy 18 risk [Likelihood] in Fetus
133
1087
1.24
1.57
1.6
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
69
519
1.34
1.54
3.2
2.8
kpa
5.1
5.1
0.05
62
489
(3012501) Base excess in Blood by calculation
31
200
1.56
1.54
4.6
2.6
mmol/l
2.4
2.4
0.03
21
119
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
537
1.33
1.53
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
68
511
1.34
1.53
3.2
2.7
ph
7.4
7.4
—
7
75
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
126
1534
0.81
1.52
1.9
1.8
—
—
—
0
0
(4024509)
17
93
1.84
1.51
2.2
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
327
2908
1.15
1.51
1.6
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
342
3819
0.87
1.51
5.8
6.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
19
108
1.77
1.50
1.5
1.2
—
40.7
—
0
11
(3017704) Immunofixation for Urine
6
21
2.86
1.50
1.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
51
2.16
1.50
1.7
4.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
116
1.73
1.49
1.2
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
111
1364
0.80
1.47
3.1
2.3
u/l
28.4
34.2
1.54
93
1167
(3003740) Influenza virus B Ag [Presence] in Specimen
31
462
0.67
1.46
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
462
0.67
1.46
1.3
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
68
516
1.33
1.45
1.9
2.4
ng/l
78.8
83.8
0.09
60
453
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
364
3270
1.14
1.45
1.9
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
244
1.48
1.45
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
135
1117
1.22
1.44
3.5
4.5
%
0.0
0.1
0.78
29
242
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
16
3.13
1.44
1.4
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
16
3.13
1.44
17.0
4.4
—
—
—
0
0
(4306422)
42
295
1.43
1.42
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
377
3400
1.14
1.42
1.8
1.6
mmol/l
1.3
1.3
0.03
323
3018
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
46
2.18
1.40
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
46
2.18
1.40
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
46
2.18
1.40
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
46
2.18
1.40
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
531
4893
1.12
1.40
2.1
2.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
65
495
1.32
1.37
2.7
2.7
mmol/l
1.5
1.1
0.28
37
343
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
17
2.95
1.36
1.2
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
117
961
1.23
1.35
1.1
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
38
0.00
1.34
0.0
8.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
18
105
1.72
1.33
3.4
1.6
%
125.7
111.1
0.41
18
98
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
34
233
1.47
1.32
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
133
1115
1.21
1.27
1.7
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
48
2.09
1.27
1.5
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
22
139
1.59
1.23
1.2
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
719
6773
1.10
1.22
2.3
2.2
nmol/l
72.4
73.5
0.56
674
6389
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
41
297
1.39
1.21
1.2
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
115
957
1.21
1.20
2.3
2.4
%
1.6
1.7
0.37
102
838
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
144
0.48
1.20
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
288
2582
1.14
1.20
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
115
958
1.21
1.19
1.7
2.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
38
2.11
1.18
1.4
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
29
198
1.47
1.17
1.7
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
137
1165
1.19
1.15
3.4
4.4
%
1.2
0.8
0.25
29
263
(3033658) Prothrombin time (PT) actual/Normal
304
3355
0.89
1.13
4.0
3.1
%
98.0
99.2
0.42
290
3252
(3025130) Human papilloma virus identified in Specimen
48
629
0.76
1.12
1.8
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
135
1.56
1.11
1.3
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
66
1.82
1.09
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
41
1.96
1.09
1.0
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
216
2428
0.88
1.07
1.6
1.7
%
1.3
1.3
0.06
197
2207
(3005719) IgG [Mass/volume] in Serum or Plasma
136
1164
1.18
1.07
1.9
2.5
g/l
10.4
10.6
0.20
131
1082
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
153
1.51
1.06
1.2
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
369
3385
1.11
1.06
2.9
2.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
46
1.96
1.03
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
46
1.96
1.03
1.3
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
96
800
1.21
1.02
4.5
3.7
ng/l
80.2
75.6
0.18
84
722
(3002179) Metamyelocytes/100 leukocytes in Blood
126
1078
1.18
1.01
3.4
4.2
%
1.2
0.7
0.35
23
188
(40768793) Breast Pathology biopsy report
38
506
0.75
1.01
1.3
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
48
1.88
1.00
1.1
1.7
ug/l
7.8
7.9
—
9
48
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
110
0.45
1.00
2.2
2.9
u/ml
321.2
730.8
—
5
110
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1155
11920
0.92
1.00
2.8
2.7
u/l
33.7
31.6
0.43
1104
11483
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
35
2.00
1.00
1.7
1.1
nmol/l
99.5
63.2
—
7
25
(3000492) Spirometry study
149
1708
0.86
0.99
1.3
1.3
—
—
—
0
0
(4094501)
31
223
1.40
0.98
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
156
1.48
0.98
3.3
2.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
161
0.56
0.98
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
31
0.00
0.96
0.0
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
77
632
1.23
0.96
1.8
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
15
235
0.64
0.96
1.5
2.0
g/l
0.0
0.3
1.90
15
216
(3025159) Blasts/100 leukocytes in Blood
126
1084
1.17
0.96
3.6
4.5
%
0.0
0.4
0.58
25
203
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
124
1066
1.17
0.95
2.5
2.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
338
3107
1.11
0.94
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
37
1.90
0.94
1.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
37
1.90
0.94
1.0
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
119
0.50
0.93
1.3
1.4
umol/l
9.5
9.4
—
6
110
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
269
1.34
0.92
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
71
581
1.23
0.92
2.6
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
456
4259
1.09
0.91
3.6
4.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
428
3988
1.09
0.90
1.4
1.4
g/l
2.0
2.1
1.43
295
2615
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
102
0.49
0.89
2.2
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
170
1913
0.88
0.89
1.5
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
42
1.91
0.88
1.0
1.4
—
—
—
0
0
(4035726)
86
1020
0.84
0.88
1.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
652
6855
0.93
0.87
1.9
1.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
307
1.31
0.87
1.2
1.3
u/ml
2.5
3.3
0.66
14
124
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
14
217
0.64
0.87
1.5
1.8
g/l
0.0
0.0
0.50
14
206
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
30
2.00
0.87
1.5
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
20
136
1.48
0.86
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
25
178
1.41
0.86
1.3
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
516
4860
1.08
0.85
3.8
3.2
e6/l
48.4
58.3
0.28
368
3028
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
137
1.46
0.84
1.1
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
58
470
1.24
0.84
1.3
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1559
15320
1.10
0.84
3.8
3.2
mmol/l
4.8
4.8
0.50
1493
14720
(4010399)
100
856
1.18
0.83
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
44
345
1.28
0.83
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1569
15427
1.10
0.82
4.0
3.4
mmol/l
2.9
2.9
0.97
1490
14708
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
138
1.45
0.81
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
73
1.65
0.81
1.3
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
14
213
0.65
0.81
1.4
1.9
g/l
41.5
39.3
3.97
14
195
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
13
201
0.64
0.81
1.5
1.9
g/l
0.0
0.0
0.50
13
191
(3045424) Erythrocytes [Presence] in Urine
32
241
1.33
0.80
1.6
1.6
—
—
—
0
0
(4281824)
13
200
0.65
0.80
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
58
1.73
0.79
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
44
552
0.79
0.79
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
20
139
1.44
0.79
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
103
889
1.17
0.79
1.4
1.8
g/l
1.2
1.3
0.47
96
827
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
223
0.67
0.78
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
223
0.67
0.78
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
13
199
0.65
0.78
1.5
1.9
g/l
0.0
0.0
0.00
13
190
(3011288) Drugs identified in Urine by Screen method
102
881
1.17
0.78
2.0
2.5
—
—
—
0
0
(1002224) Polysomnography panel
68
812
0.83
0.77
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
170
1523
1.13
0.77
3.1
2.2
umol/l
6.8
5.2
0.45
145
1258
(3022689) Creatine [Moles/volume] in Urine
6
34
1.77
0.76
1.3
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
91
781
1.17
0.75
1.6
1.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
24
2.09
0.74
1.4
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
24
2.09
0.74
8.2
6.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
524
0.80
0.73
1.3
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
100
1.50
0.73
1.3
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
153
1370
1.13
0.71
1.3
1.3
u/ml
124.1
232.4
0.81
138
1271
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
160
1.38
0.70
1.3
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
26
195
1.34
0.69
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
85
1.53
0.69
1.3
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.85
0.68
1.4
3.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.85
0.68
1.4
3.8
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
9
59
1.53
0.68
2.4
1.8
—
144.1
—
0
8
(3022217) INR in Platelet poor plasma by Coagulation assay
106
931
1.15
0.67
5.8
9.8
inr
1.2
1.1
0.28
18
173
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1548
15250
1.08
0.66
3.8
3.2
mmol/l
1.5
1.6
8.41
1479
14611
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
78
1.54
0.65
1.3
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
120
1.42
0.64
1.4
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
13
87
1.50
0.63
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
515
4907
1.07
0.63
1.8
1.7
pmol/l
97.3
100.3
0.81
294
2708
(3042517) Benzodiazepines panel - Urine
5
30
1.67
0.61
1.2
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
194
1779
1.10
0.61
3.6
3.1
mmol/l
0.8
0.8
0.94
183
1677
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
57
673
0.84
0.61
1.4
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
88
1.48
0.60
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
122
1359
0.89
0.59
3.0
3.1
%
31.9
32.5
0.27
102
1031
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
97
1.45
0.59
1.4
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
24
184
1.31
0.58
3.3
1.8
mu/l
26.3
46.8
1.49
24
167
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
35
1.72
0.57
1.3
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
346
1.22
0.57
1.3
1.3
ug/g
302.4
314.3
0.10
20
174
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
319
1.23
0.57
1.2
1.2
u/ml
1.6
2.9
1.06
15
111
(3044941) Cell count panel - Synovial fluid
21
158
1.33
0.57
1.3
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
36
1.67
0.56
2.7
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
25
194
1.29
0.56
1.7
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
37
1.62
0.55
1.3
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
125
0.64
0.54
1.6
1.6
umol/l
30.2
22.2
—
8
117
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
61
707
0.86
0.54
1.3
1.5
nmol/l
0.6
0.5
0.34
52
577
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.0
2.1
ug/l
11.1
21.7
—
6
38
(3018010) Neutrophils/100 leukocytes in Blood
747
7714
0.95
0.54
5.2
5.7
%
57.4
56.4
1.92
701
7316
(40765089) Chromosome analysis panel - Blood by G-banded
14
99
1.42
0.54
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
216
2006
1.09
0.53
1.2
1.2
iu/ml
137.9
159.6
0.40
87
802
(3011648) Oxygen content in Venous blood
11
74
1.49
0.53
2.8
2.8
%
10.1
11.1
0.51
11
74
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
169
1.31
0.53
1.4
1.4
g/l
0.4
0.4
0.21
13
114
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
169
1.31
0.53
1.4
1.4
g/l
3.2
3.0
0.18
13
114
(40768797) Stomach Pathology biopsy report
198
1833
1.09
0.53
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
34
277
1.23
0.52
3.4
2.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
755
7789
0.95
0.52
5.2
5.8
%
29.3
29.9
1.18
713
7375
(3022313) Gas panel - Capillary blood
41
341
1.21
0.52
3.0
2.9
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
170
1.30
0.51
1.4
1.4
g/l
6.8
6.1
0.60
13
116
(4062490)
22
170
1.30
0.51
1.5
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
124
1124
1.11
0.51
1.4
1.3
miu/ml
278.7
244.9
0.41
60
595
(3034426) Prothrombin time (PT)
11
75
1.47
0.50
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
42
498
0.84
0.50
1.0
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
189
2034
0.92
0.49
2.1
2.3
mmol/l
2.4
2.4
0.11
170
1777
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
323
0.80
0.49
2.9
3.3
e9/l
3.9
4.0
0.09
26
323
(44813793)
20
154
1.30
0.48
1.1
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
42
496
0.84
0.48
1.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
76
1.45
0.48
2.0
3.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
128
1.33
0.47
1.7
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
42
495
0.85
0.47
1.0
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1465
14458
1.06
0.47
8.7
7.9
ml/min/173m2
96.7
94.5
4.69
1210
11705
(40767503) Oxygen content in Capillary blood by calculation
24
191
1.26
0.46
3.8
1.9
%
16.1
16.9
0.35
13
100
(3015377) Calcium [Moles/volume] in Serum or Plasma
411
4293
0.95
0.45
2.9
3.1
mmol/l
2.3
2.3
0.40
380
3914
(3028433) Virus identified in Specimen by Culture
7
51
1.37
0.44
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
13
95
1.37
0.43
3.6
1.5
%
101.2
102.2
0.05
13
85
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
211
1.24
0.43
3.2
2.8
—
1035.8
—
0
12
(40768795) Lymph node Pathology biopsy report
9
127
0.71
0.43
1.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
166
1.27
0.43
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
166
1.27
0.43
1.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
166
1.27
0.43
1.1
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
691
6709
1.05
0.43
2.7
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
393
0.84
0.43
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
27
328
0.82
0.43
3.0
3.5
%
56.6
56.7
0.02
27
328
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
116
1265
0.91
0.42
1.3
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
25
203
1.23
0.42
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
90
994
0.90
0.42
1.4
1.7
mg/l
4.5
4.2
0.08
68
661
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
63
557
1.14
0.42
1.8
1.6
iu/ml
0.0
0.2
—
9
99
(3049717) Cytology report of Urine Cyto stain
14
184
0.76
0.41
2.1
2.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
123
1131
1.09
0.41
1.2
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.7
—
0.3
—
0
15
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
8
59
1.36
0.41
2.8
2.6
%
7.0
7.3
—
8
59
(21494814) CD8 cells/100 lymphocytes in Specimen
8
59
1.36
0.41
2.5
2.5
—
—
—
0
0
(4015189)
0
17
0.00
0.40
0.0
4.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
94
854
1.11
0.40
1.2
1.3
u/l
14.5
10.5
1.71
81
694
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
315
1.18
0.40
1.1
1.1
—
—
—
0
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
1.8
—
0
12
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
1.1
—
0
13
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
2.4
—
0
13
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
5.4
—
0
13
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
0.6
—
0
12
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.4
—
0.7
—
0
13
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
105
0.67
0.39
1.1
1.2
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
0
19
0.00
0.39
0.0
1.5
—
1.7
—
0
14
(3007542) Rye IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.2
—
0
7
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
60
532
1.13
0.39
1.5
1.3
u/ml
7.2
44.8
—
5
46
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
115
1.31
0.39
1.3
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
169
1.25
0.38
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
27
224
1.21
0.38
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
36
1.39
0.38
1.4
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
36
1.39
0.38
1.4
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
89
1.35
0.38
1.2
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
64
572
1.12
0.37
1.1
1.1
u/ml
5.8
1.3
0.91
22
223
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
112
0.71
0.37
1.6
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
37
1.35
0.37
1.4
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
159
1487
1.08
0.37
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
116
0.69
0.37
2.3
2.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
118
1092
1.09
0.36
1.1
1.1
titre
196.7
120.2
—
6
26
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
180
1.22
0.36
2.9
3.8
u/ml
0.3
0.3
—
10
86
(3022096) Basophils/100 leukocytes in Blood
700
7175
0.96
0.35
5.3
5.9
%
0.6
0.7
0.85
661
6752
(3000012) Reticulocyte production index
6
44
1.36
0.34
1.3
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
21
172
1.22
0.34
1.4
1.9
nmol/l
18.6
20.0
0.41
21
166
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
20
163
1.23
0.34
1.1
3.2
mg/l
28.9
24.3
0.18
14
135
(3034860) Kappa light chains.free [Mass/volume] in Serum
20
163
1.23
0.34
1.1
3.2
mg/l
52.8
33.0
0.43
14
137
(3052851) Hemolysis interference index of Serum or Plasma
32
371
0.86
0.33
2.1
2.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
5.5
2.2
—
—
—
0
0
(4027681)
21
173
1.22
0.33
1.1
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
130
1214
1.08
0.33
1.7
2.3
e9/l
3.9
4.1
0.46
112
1030
(3016879) Cocaine [Presence] in Urine
125
1167
1.08
0.32
1.7
1.9
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
12
92
1.31
0.31
1.1
1.5
u/l
5.2
5.4
0.07
12
76
(40760888) Immunoglobulin light chains.free panel - Serum
15
119
1.26
0.31
1.1
3.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
174
1.21
0.31
1.1
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
727
7430
0.97
0.31
5.2
5.9
%
2.7
2.7
0.14
684
6992
(40768446) Kidney Pathology biopsy report
7
52
1.35
0.31
2.7
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
93
859
1.09
0.31
3.7
3.5
ug/l
57.7
51.0
0.03
66
605
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
68
746
0.91
0.31
1.7
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1619
16072
1.05
0.30
11.5
10.5
%
38.7
39.7
5.18
1244
13737
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
54
1.30
0.30
1.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
38
334
1.14
0.30
1.3
1.6
—
5.3
—
0
9
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
120
1.25
0.30
1.3
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
55
1.27
0.30
1.1
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
731
7464
0.97
0.30
5.4
6.1
%
7.7
7.9
0.91
693
7088
(3027008) Opiates [Presence] in Urine
136
1279
1.07
0.29
1.6
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
134
1260
1.07
0.29
2.3
2.3
au/ml
12.2
24.5
—
9
98
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
213
1.18
0.29
1.1
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
34
387
0.88
0.29
1.1
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
806
8212
0.97
0.29
5.2
5.9
e9/l
2.0
2.0
0.93
747
7457
(3000764) Benzodiazepines [Presence] in Urine
135
1273
1.07
0.27
1.6
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1478
14654
1.04
0.27
3.4
3.0
mmol/l
1.2
1.2
0.55
1410
14035
(3006462) Nitrate [Presence] in Urine
8
64
1.25
0.27
3.3
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
192
2012
0.95
0.27
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
59
538
1.10
0.27
2.2
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
468
4806
0.97
0.26
5.2
6.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
128
1207
1.06
0.26
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
150
1.20
0.26
1.3
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
121
1283
0.94
0.26
1.1
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
136
1287
1.06
0.25
1.6
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
72
1.25
0.25
1.4
2.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
72
1.25
0.25
2.6
2.3
nmol/l
50.8
62.8
—
9
72
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
52
473
1.10
0.25
1.5
1.4
u/ml
5.7
6.6
—
5
57
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
9
74
1.22
0.25
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
349
1.12
0.25
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
105
1.24
0.24
1.0
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
198
1.16
0.24
1.8
2.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
36
321
1.12
0.24
1.2
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.2
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
53
484
1.10
0.24
1.5
1.4
u/ml
1.5
11.8
—
10
96
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
133
1.20
0.24
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
147
0.82
0.23
2.1
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
179
1869
0.95
0.23
3.0
2.5
e6/l
5.7
5.0
0.30
104
922
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
171
1.17
0.23
1.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
171
1.17
0.23
1.1
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
173
1655
1.05
0.23
1.5
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
106
1.23
0.23
1.8
1.8
%
37.4
47.8
—
8
68
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
136
0.81
0.23
1.5
1.4
g/l
0.9
0.9
0.02
11
136
(3024471) HLA-A [Type]
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.8
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.8
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
155
1482
1.05
0.21
1.5
1.7
mu/l
288.1
326.4
0.72
133
1317
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
42
1.19
0.21
1.2
1.4
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
905
8930
1.03
0.21
7.0
8.9
e9/l
4.2
4.0
1.40
822
7942
(3011048) Pyruvate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
72.2
—
0
12
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
1.1
—
0
7
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.7
—
355.5
—
0
13
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
14
0.00
0.20
0.0
2.3
—
210.1
—
0
14
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
155
1.16
0.20
1.1
1.1
u/l
0.9
1.0
—
6
60
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
50
1.20
0.19
1.2
1.3
—
19.5
—
0
11
(3003338) MCHC [Mass/volume]
1526
15168
1.03
0.19
14.1
12.1
g/l
332.6
331.8
3.27
1520
15028
(3027944) Amphetamines [Presence] in Urine
133
1271
1.05
0.19
1.6
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
17
197
0.86
0.19
1.8
1.3
—
—
—
0
0
(4198724)
14
118
1.19
0.19
2.1
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
184
1.14
0.19
1.2
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
175
0.86
0.18
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
53
1.13
0.18
1.3
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
109
1.19
0.18
1.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
108
1030
1.05
0.18
3.4
3.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
60
1.17
0.17
1.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
60
1.17
0.17
1.0
1.2
%
85.0
97.7
—
7
60
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
131
0.84
0.17
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
67
0.75
0.17
1.2
2.2
umol/l
29.6
29.4
—
5
62
(3010838) Calcium [Moles/time] in 24 hour Urine
5
68
0.73
0.17
1.2
1.4
—
5.6
—
0
9
(3023323) Follitropin [Units/volume] in Serum or Plasma
218
2116
1.03
0.16
1.2
1.3
iu/l
24.1
23.7
0.06
193
1815
(4146454)
8
68
1.18
0.16
3.1
3.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
8
72
1.11
0.16
1.4
1.6
mg/l
2.8
2.6
—
8
66
(3014133) Dog dander IgE Ab [Units/volume] in Serum
48
448
1.07
0.15
1.0
1.1
u/ml
1.9
4.3
0.55
15
164
(3026389) Candida sp identified in Specimen by Organism specific culture
29
265
1.10
0.14
1.3
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
112
1.16
0.14
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
40
372
1.08
0.14
1.4
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
96
0.83
0.13
1.8
1.2
—
63.3
—
0
12
(3021788) Differential panel - Synovial fluid
20
180
1.11
0.13
1.2
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
108
0.83
0.13
2.2
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
18
161
1.12
0.13
3.4
3.4
u/ml
39.8
35.1
0.12
18
161
(3000093) Morphology [Interpretation] in Blood Narrative
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
20
181
1.11
0.12
1.0
1.0
—
0.4
—
0
54
(3003888) Timothy IgE Ab [Units/volume] in Serum
55
522
1.06
0.12
1.0
1.1
u/ml
3.3
5.7
0.77
22
283
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
46
434
1.06
0.12
5.8
4.0
mmol/l
24.2
24.1
0.07
37
396
(3023419) Bacteria identified in Sputum by Culture
11
95
1.16
0.11
1.5
3.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
43
406
1.06
0.11
1.0
1.1
u/ml
5.2
3.9
0.19
13
162
(3048689) Calprotectin [Mass/mass] in Stool
272
2673
1.02
0.10
2.5
2.4
ug/g
125.7
97.5
0.55
219
2065
(3042733) HLA Ab [Presence] in Serum
5
44
1.14
0.10
5.2
5.1
—
—
—
0
0
(4133840)
5
45
1.11
0.09
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.8
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
19
207
0.92
0.09
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
87
1.15
0.09
1.2
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
17
155
1.10
0.09
2.2
2.8
e9/l
1.3
1.2
—
7
88
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
126
1.11
0.09
1.4
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
206
0.92
0.08
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
51
489
1.04
0.08
1.0
1.1
u/ml
0.4
0.9
0.95
15
215
(3024928) Oxygen saturation in Venous blood
17
185
0.92
0.08
7.4
3.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
117
1.11
0.08
1.2
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
18
195
0.92
0.08
1.4
1.4
—
37.0
—
0
5
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
313
1.06
0.07
1.1
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
75
0.80
0.07
1.0
2.0
ug/l
0.2
1.4
—
6
69
(3006653) Thiamine [Moles/volume] in Blood
8
74
1.08
0.07
1.5
1.7
nmol/l
121.9
133.3
—
8
74
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
44
459
0.96
0.07
1.4
1.5
—
—
—
0
0
(4211845)
8
75
1.07
0.07
3.3
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
80
0.87
0.07
1.0
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
84
0.83
0.07
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
49
509
0.96
0.07
1.0
1.1
u/ml
1.4
1.2
0.09
11
117
(3009871) Measles virus Ab [Titer] in Serum
9
85
1.06
0.07
2.0
1.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
105
0.86
0.06
1.4
1.3
—
223.2
—
0
22
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
105
0.86
0.06
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
55
533
1.03
0.06
2.1
2.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
129
1.09
0.05
4.7
7.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
90
1.11
0.05
1.2
1.2
—
—
—
0
0
(4268621)
24
228
1.05
0.05
1.7
2.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
22
232
0.95
0.05
1.1
1.8
—
28.7
—
0
12
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
171
0.94
0.05
1.1
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
785
7884
0.99
0.05
5.2
5.9
e9/l
0.5
0.5
1.01
718
7047
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
120
1.08
0.05
1.7
1.4
promille
0.6
1.1
—
8
95
(3017446) Testosterone [Moles/volume] in Serum or Plasma
37
357
1.04
0.04
1.2
1.3
nmol/l
1.0
1.5
2.01
29
290
(3014051) Protein [Presence] in Urine by Test strip
29
302
0.96
0.04
2.1
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
91
1.10
0.04
2.2
3.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
39
378
1.03
0.04
1.1
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
822
8193
1.01
0.03
5.2
6.3
e9/l
0.2
0.2
0.61
762
7414
(3006315) Basophils [#/volume] in Blood
789
7915
0.99
0.03
5.2
5.9
e9/l
0.0
0.0
0.71
720
7051
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
169
0.95
0.03
1.6
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
110
1087
1.01
0.03
2.3
2.3
ml/min/173m2
78.1
80.6
0.27
39
401
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
40
390
1.03
0.02
1.1
1.0
u/ml
0.9
2.2
3.65
23
241
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
259
0.96
0.02
1.6
1.6
g/l
0.8
0.7
0.30
15
189
(21494815) CD4 cells/100 lymphocytes in Specimen
13
138
0.94
0.02
2.5
2.4
%
47.0
46.0
—
5
23
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
128
1268
1.01
0.02
1.5
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
135
1338
1.01
0.02
1.9
2.3
u/ml
21.6
35.6
3.39
129
1296
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
198
1969
1.01
0.01
2.8
2.3
e6/l
1.0
1.1
0.12
121
1016
(3003327) Ova and parasites identified in Stool by Light microscopy
78
789
0.99
0.01
1.7
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
13
124
1.05
0.00
1.8
2.7
e6/l
523.9
477.0
0.23
13
102
(3000991) Gas panel - Venous blood
70
706
0.99
0.00
10.0
7.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
105
1.05
0.00
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
115
0.96
0.00
2.5
2.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
12
121
0.99
0.00
1.7
2.7
e9/l
0.2
0.2
0.21
12
101
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
121
0.99
0.00
1.3
1.3
ug/l
6.3
6.3
0.00
12
102
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
271
1.00
0.00
1.3
1.8
g/l
3.3
3.8
1.37
17
206
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
271
1.00
0.00
1.3
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
144
0.97
0.00
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
144
0.97
0.00
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
144
0.97
0.00
1.1
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
18
178
1.01
0.00
1.9
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
142
0.99
0.00
1.6
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
108
1.02
0.00
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
272
0.99
0.00
1.3
1.8
g/l
7.2
7.3
0.20
18
222
(3016018) Differential panel - Cerebral spinal fluid
18
182
0.99
0.00
1.7
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
143
0.98
0.00
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
143
0.98
0.00
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
143
0.98
0.00
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
253
0.99
0.00
3.0
4.6
u/ml
33.3
68.9
—
9
73
(4034850)
45
447
1.01
0.00
7.3
6.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.9
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.3
1.8
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
8
0.00
0.00
0.0
1.3
—
64.5
—
0
8
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.3
1.8
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
252.8
—
0
6
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
7
79
0.89
0.00
4.3
6.5
mg/l
9.7
11.0
—
7
74
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.3
1.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
13.0
—
0
8
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
8.4
—
0
7
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
63
0.95
0.00
4.5
1.9
umol/l
14.7
16.6
—
6
63
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
8
0.00
0.00
0.0
1.3
—
28.3
—
0
8
(21494890) Protein electrophoresis panel - 24 hour Urine
6
59
1.02
0.00
1.0
1.7
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
26.0
—
0
5
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.3
—
8.2
—
0
8
(3015076) Soybean IgE Ab [Units/volume] in Serum
18
180
1.00
0.00
1.0
1.0
—
0.2
—
0
23
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.3
1.8
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
54
0.93
0.00
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
100
1.00
0.00
2.4
2.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
64
0.94
0.00
2.7
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
50
1.00
0.00
1.2
1.9
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
60
1.00
0.00
1.3
1.8
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.3
—
2.4
—
0
8
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
81
0.99
0.00
1.4
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint O15_POLYHYDR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_POLYHYDR.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: O15_POLYHYDR – Polyhydramnios

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data